Table 1.

Total group and U3RNP+ group, SSc pattern, capillary loss, and organ involvement.

Cardiac Involvement (negative)Cardiac Involvement (positive)Pulmonary Involvement (negative)Pulmonary Involvement (positive)
Alln = 37n = 8n = 42n = 3
  Early, n = 98 (22)1 (13)9 (21)0 (0)
  Active, n = 2018 (47)2 (26)20 (58)0 (0)
  Late, n = 106 (17)4 (52)7 (17)3 (100)*
  Secondary, n = 65 (14)1 (13)6 (14)0 (0)
U3RNP+n = 13n = 2n = 15n = 0
  Early, n = 11 (8)0 (0)1 (6)0 (0)
  Active, n = 66 (46)0 (0)6 (40)0 (0)
  Late, n = 43 (23)1 (50)4 (27)0 (0)
  Secondary, n = 43 (23)1 (50)4 (27)0 (0)
Alln = 37n = 8n = 42n = 3
  Capillary loss (−), n = 2624 (65)2 (25)26 (62)0 (0)
  Capillary loss (+), n = 1913 (35)6 (75)**16 (38)3 (100)
U3RNP+n = 13n = 2n = 15n = 0
  Capillary loss (−), n = 88 (61)0 (0)8 (53)0 (0)
  Capillary loss (+), n = 75 (39)2 (100)7 (47)0 (0)
  • Values are n (%) unless otherwise specified.

  • * P value = 0.009 chi square; late pattern vs non late pattern.

  • ** P value = 0.047 chi square; capillary loss vs no loss, all other comparisons nonsignificant. Cardiac involvement defined as a Medsger score of 1 or higher, or at least 2 of the following: decreased LVEF, arrhythmias, conduction abnormalities, diastolic dysfunction, or pericardial effusion. Pulmonary involvement defined as decreased FVC and DLCO and ILD on HRCT. SSc: systemic sclerosis; LVEF: left ventricular ejection fraction; FVC: forced vital capacity; ILD: interstitial lung disease; HRCT: high-resolution computed tomography.